Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 12.916% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] C/C(N)=C(/C#N)C(=O)CSc1nn(-c2ccc(Cl)cc2)c(=S)s1
[b] CC(C)OP(=O)(c1ccccc1)c1ccccc1
Answer: a. C/C(N)=C(/C#N)C(=O)CSc1nn(-c2ccc(Cl)cc2)c(=S)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C/C(N)=C(/C#N)C(=O)CSc1nn(-c2ccc(Cl)cc2)c(=S)s1
C/C(N)=C(/C#N)C(=O)CSc1nn(-c2ccc(Cl)cc2)c(=S)s1
(E)-3-amino-2-[2-[[4-(4-chlorophenyl)-5-sulfanylidene-1,3,4-thiadiazol-2-yl]sulfanyl]acetyl]but-2-enenitrile